BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su CY, Li JQ, Zhang LL, Wang H, Wang FH, Tao YW, Wang YQ, Guo QR, Li JJ, Liu Y, Yan YY, Zhang JY. The Biological Functions and Clinical Applications of Integrins in Cancers. Front Pharmacol 2020;11:579068. [PMID: 33041823 DOI: 10.3389/fphar.2020.579068] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Quaglia F, Krishn SR, Sossey-alaoui K, Rana PS, Pluskota E, Park PH, Shields CD, Lin S, Mccue P, Kossenkov AV, Wang Y, Goodrich DW, Ku S, Beltran H, Kelly WK, Corey E, Klose M, Bandtlow C, Liu Q, Altieri DC, Plow EF, Languino LR. The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer. Sci Rep 2022;12:18879. [DOI: 10.1038/s41598-022-21711-5] [Reference Citation Analysis]
2 Seo S, Hong N, Song J, Kim D, Choi Y, Lee D, Jon S, Kim H. Polymer Thin Film Promotes Tumor Spheroid Formation via JAK2-STAT3 Signaling Primed by Fibronectin-Integrin α5 and Sustained by LMO2-LDB1 Complex. Biomedicines 2022;10:2684. [DOI: 10.3390/biomedicines10112684] [Reference Citation Analysis]
3 Gusmão LA, Matsuo FS, Barbosa HFG, Tedesco AC. Advances in nano-based materials for glioblastoma multiforme diagnosis: A mini-review. Front Nanotechnol 2022;4. [DOI: 10.3389/fnano.2022.836802] [Reference Citation Analysis]
4 Cuypers A, Truong AK, Becker LM, Saavedra-garcía P, Carmeliet P. Tumor vessel co-option: The past & the future. Front Oncol 2022;12:965277. [DOI: 10.3389/fonc.2022.965277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Teixeira SA, Burim RV, Viapiano MS, Bidinotto LT, Nagashi Marie SK, Fleury Malheiros SM, Oba-shinjo SM, Andrade AF, Carlotti CG. Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients. Front Oncol 2022;12:914156. [DOI: 10.3389/fonc.2022.914156] [Reference Citation Analysis]
6 Lugun O, Pandey AK. Nanoparticles Targeting and Uptake: Current Advances in Breast Cancer Research. Breast Cancer: Current Trends in Molecular Research 2022. [DOI: 10.2174/9781681089522112010011] [Reference Citation Analysis]
7 Ucaryilmaz Metin C, Ozcan G. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer. BMC Cancer 2022;22:692. [PMID: 35739492 DOI: 10.1186/s12885-022-09736-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hargadon KM, Goodloe TB 3rd, Lloyd ND. Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective. Cancer Metastasis Rev 2022. [PMID: 35701636 DOI: 10.1007/s10555-022-10045-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lin X, Kong D, Chen ZS. Editorial: Chemo-Radiation-Resistance in Cancer Therapy. Front Pharmacol 2022;13:904063. [PMID: 35662703 DOI: 10.3389/fphar.2022.904063] [Reference Citation Analysis]
10 Sugár S, Bugyi F, Tóth G, Pápay J, Kovalszky I, Tornóczky T, Drahos L, Turiák L. Proteomic Analysis of Lung Cancer Types—A Pilot Study. Cancers 2022;14:2629. [DOI: 10.3390/cancers14112629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Aleman JD, Young CD, Karam SD, Wang XJ. Revisiting laminin and extracellular matrix remodeling in metastatic squamous cell carcinoma: What have we learned after more than four decades of research? Mol Carcinog 2022. [PMID: 35596706 DOI: 10.1002/mc.23417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Balma M, Liberini V, Racca M, Laudicella R, Bauckneht M, Buschiazzo A, Nicolotti DG, Peano S, Bianchi A, Albano G, Quartuccio N, Abgral R, Morbelli SD, D'Alessandria C, Terreno E, Huellner MW, Papaleo A, Deandreis D. Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review. Front Med (Lausanne) 2022;9:881551. [PMID: 35492341 DOI: 10.3389/fmed.2022.881551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ripamonti M, Wehrle-haller B, de Curtis I. Paxillin: A Hub for Mechano-Transduction from the β3 Integrin-Talin-Kindlin Axis. Front Cell Dev Biol 2022;10:852016. [DOI: 10.3389/fcell.2022.852016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sudha T, Godugu K, Glinsky GV, Mousa SA. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022;10:795. [DOI: 10.3390/biomedicines10040795] [Reference Citation Analysis]
15 Augustine D, Rao RS, Surendra L, Gupta B, Yoithapprabhunath TR, Yadalam PK, Mushtaq S, Ahmed ZH, Patil S. Subepithelial Hyalinisation Predicts Recurrence of Unicystic Ameloblastomas. Diagnostics 2022;12:756. [DOI: 10.3390/diagnostics12030756] [Reference Citation Analysis]
16 Pozdniakova NV, Ryabaya OV, Semkina AS, Skribitsky VA, Shevelev AB. Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells. Int J Mol Sci 2022;23:3297. [PMID: 35328725 DOI: 10.3390/ijms23063297] [Reference Citation Analysis]
17 Hou W, Bridgeman B, Malnassy G, Ding X, Cotler SJ, Dhanarajan A, Qiu W. Integrin subunit beta 8 contributes to lenvatinib resistance in HCC. Hepatol Commun 2022. [PMID: 35238496 DOI: 10.1002/hep4.1928] [Reference Citation Analysis]
18 Pérez LA, Leyton L, Valdivia A. Thy-1 (CD90), Integrins and Syndecan 4 are Key Regulators of Skin Wound Healing. Front Cell Dev Biol 2022;10:810474. [DOI: 10.3389/fcell.2022.810474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Casali BC, Gozzer LT, Baptista MP, Altei WF, Selistre-de-Araújo HS. The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro. Int J Mol Sci 2022;23:1745. [PMID: 35163668 DOI: 10.3390/ijms23031745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sani S, Pallaoro N, Messe M, Bernhard C, Etienne-Selloum N, Kessler H, Marinelli L, Entz-Werle N, Foppolo S, Martin S, Reita D, Dontenwill M. Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin. Cancers (Basel) 2022;14:369. [PMID: 35053532 DOI: 10.3390/cancers14020369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Pandey S, Nisha, Jain BP. Alteration in major cell signaling pathways in cancer. Understanding Cancer 2022. [DOI: 10.1016/b978-0-323-99883-3.00002-0] [Reference Citation Analysis]
22 Deng S, Li L, Xu S, Wang X, Han T. Promotion of gastric tumor initiating cells in a 3D collagen gel culture model via YBX1/SPP1/NF-κB signaling. Cancer Cell Int 2021;21:599. [PMID: 34758833 DOI: 10.1186/s12935-021-02307-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xiong J, Yan L, Zou C, Wang K, Chen M, Xu B, Zhou Z, Zhang D. Integrins regulate stemness in solid tumor: an emerging therapeutic target. J Hematol Oncol 2021;14:177. [PMID: 34715893 DOI: 10.1186/s13045-021-01192-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
24 Mia MS, Jarajapu Y, Rao R, Mathew S. Integrin β1 Promotes Pancreatic Tumor Growth by Upregulating Kindlin-2 and TGF-β Receptor-2. Int J Mol Sci 2021;22:10599. [PMID: 34638957 DOI: 10.3390/ijms221910599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ungai-Salánki R, Haty E, Gerecsei T, Francz B, Béres B, Sztilkovics M, Székács I, Szabó B, Horvath R. Single-cell adhesion strength and contact density drops in the M phase of cancer cells. Sci Rep 2021;11:18500. [PMID: 34531409 DOI: 10.1038/s41598-021-97734-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Höltke C, Alsibai W, Grewer M, Stölting M, Geyer C, Eisenblätter M, Wildgruber M, Helfen A. How Different Albumin-Binders Drive Probe Distribution of Fluorescent RGD Mimetics. Front Chem 2021;9:689850. [PMID: 34504831 DOI: 10.3389/fchem.2021.689850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Gaurav I, Wang X, Thakur A, Iyaswamy A, Thakur S, Chen X, Kumar G, Li M, Yang Z. Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer. Pharmaceutics 2021;13:1433. [PMID: 34575511 DOI: 10.3390/pharmaceutics13091433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Picoli CC, Gonçalves BÔP, Santos GSP, Rocha BGS, Costa AC, Resende RR, Birbrair A. Pericytes cross-talks within the tumor microenvironment. Biochim Biophys Acta Rev Cancer 2021;:188608. [PMID: 34384850 DOI: 10.1016/j.bbcan.2021.188608] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
29 Zamay TN, Prokopenko VS, Zamay SS, Lukyanenko KA, Kolovskaya OS, Orlov VA, Zamay GS, Galeev RG, Narodov AA, Kichkailo AS. Magnetic Nanodiscs-A New Promising Tool for Microsurgery of Malignant Neoplasms. Nanomaterials (Basel) 2021;11:1459. [PMID: 34072903 DOI: 10.3390/nano11061459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Casari I, Howard JA, Robless EE, Falasca M. Exosomal integrins and their influence on pancreatic cancer progression and metastasis. Cancer Lett 2021;507:124-34. [PMID: 33741423 DOI: 10.1016/j.canlet.2021.03.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
31 Su C, Zhang J, Yarden Y, Fu L. The key roles of cancer stem cell-derived extracellular vesicles. Signal Transduct Target Ther 2021;6:109. [PMID: 33678805 DOI: 10.1038/s41392-021-00499-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
32 Heissig B, Salama Y, Takahashi S, Okumura K, Hattori K. The Multifaceted Roles of EGFL7 in Cancer and Drug Resistance. Cancers (Basel) 2021;13:1014. [PMID: 33804387 DOI: 10.3390/cancers13051014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Niland S, Eble JA. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment. Int J Mol Sci 2020;22:E238. [PMID: 33379400 DOI: 10.3390/ijms22010238] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]